Arjuna, org (1/2 lb.)
Item Number : 6832 Price: $10.95 Quantity :
This item is out of stock. If you choose to order it, we will ship it when it becomes available.
Certified Organic Arjuna bark powder (Terminalia arjuna)
Traditional rejuvenative and tonic for the heart*
* Supports proper function of the heart* * Strengthens and tones the circulatory system* * Supports healthy blood pressure already within the normal range* * Maintains healthy cholesterol levels already within the normal range*
* Rasa (taste): astringent, bitter * Virya (action): cooling * Vipaka (post-digestive effect): pungent * Doshas (constitutions): Balancing for pitta and kapha, in excess may increase vata.
Commentary: In Ayurvedic medicine Arjuna is the foremost rejuvenative for the heart. It strengthens and tones the circulatory system and promotes proper function of the heart muscles. Arjuna's strengthening and toning actions help maintain healthy blood pressure already within the normal range. It is also used to help maintain healthy cholesterol levels and to support healthy coagulation. Arjuna is traditionally used to promote emotional balance for those experiencing grief and sadness. It is said to mend a 'broken heart' and to impart courage and strengthen the will.*
For a 1 lb bag click here For five lbs or more in bulk click here
Herbal tablets that contain Arjuna include: Heart Formula, Stress Ease, Sweet Ease
Other products that contain Arjuna include: Mahanarayan oil
This product is organically grown and processed in accordance with the USDA's National Organic Program (NOP).
For more information on Arjuna visit:
Wikipedia's entry for Terminalia arjuna
Herbs for life: arjuna monograph
Search index page description Banyan Botanicals Arjuna powder is USDA certified organic, sustainably sourced, and fairly traded. Arjuna is also known as Arjun (Hindi), Arjuna or Kakubha (Sanskrit), Arjuna Myrobalan (English) and Kumbuk (Sinhalese). The botanical name of Arjuna is Terminalia arjuna. Arjuna powder is available in ½ lb and 1 lb bags and in bulk bags of 5 lbs or more.
Botanical name: Terminalia arjuna, Combretaceae
Other names: Kakubha (‘mountain top,’ S), Arjun, Anjan, Kahu (H), Attumaratu, Nirmarutu, Vellaimarutu, Marutu (T), White Murdah (E)
ArjunaBotany: Arjuna grows to become a very large tree with a huge buttressed trunk, widely spreading, drooping branches, and a grey bark that flakes off in large, flat pieces. The leaves are opposite, simple, oblong to elliptic, pale green above and pale brown below. The white flowers are borne in short axillary spikes or terminal panicles, giving way to an ovoid or oblong fruit with 5-7 short, hard wings. Arjuna is found throughout the subcontinent of India, from the foothills of the Himalayas southwards into Sri Lanka (Warrier et al 1995, 253; Kirtikar and Basu 1935, 1024).
Part used: Bark.
Rasa: kashaya, madhura, katu *
Virya: shita *
Karma: purishasangrahaniya, chedana, kasahara, svasahara, raktasthambhana, hrdaya, mutravirechana, ashmaribhedana, vishaghna, medohara, sandaniya, vajikarana, Kaphapittahara (Srikanthamurthy 2001, 297-98; Warrier et al 1995, 252).
Constituents: Arjuna contains a number of triterpenoid saponins (e.g. arjunetoside, arjunolitin, arjunoside I-IV, terminic acid, arjunic acid, arjunolic acid, arjungenin), flavonoids (arjunone, arjunolone, luteolin), cardenolide, gallic acid, ellagic acid, oligomeric proanthocyanidins, phytosterols, tannin, calcium, magnesium, zinc, and copper (Upadhyay et al 2001; Yadav and Rathore 2001; Yoganarasimhan 2000, 551).
Antiviral: A hydrolyzable tannin isolated from the bark of Terminalia arjuna called casuarinin was investigated for its antiviral activity on herpes simplex type 2 (HSV-2) in vitro. The results showed that casuarinin prevented the attachment of HSV-2 to cells, inhibited the viral penetration, and was virucidal at a concentration of 25 microM, reducing viral titers up to 100,000-fold (Cheng et al 2002).
Cardiovascular: A double-blind, randomized, placebo-controlled study examined the efficacy of a bark extract of Terminalia arjuna in males with chronic stable angina with evidence of provocable ischemia on treadmill exercise test. Patients received a Terminalia arjuna extract (500 mg 8 hourly), isosorbide mononitrate (40 mg/daily) or a matching placebo for one week each. Terminalia arjuna therapy was associated with a significant decrease in the frequency of angina and need for isosorbide dinitrate, with significant improvements in treadmill exercise test parameters compared to those with placebo, similar to isosorbide mononitrate therapy. The extract was well tolerated (Bharani et al 2002). A triterpene identified as arjunolic acid isolated from the bark of Terminalia arjuna was shown to provide significant cardiac protection in isoproterenol-induced myocardial necrosis in rats, preventing a decrease in the levels of superoxide dismutase, catalase, glutathione peroxidase, ceruloplasmin, tocopherol, reduced glutathione (GSH), ascorbic acid, lipid peroxide, and MPO. The cardioprotective effect was confirmed by histopathological studies (Sumitra et al 2001). The dried pulverized bark of Terminalia arjuna was administered orally to Wistar albino rats in two doses (500 and 750 mg/kg in 2% carboxy methyl cellulose), 6 days per week for 12 weeks, and then sacrificed to determine baseline changes in endogenous cardiac antioxidant compounds, including superoxide dismutase (SOD), reduced glutathione (GSH) and catalase (CAT). The hearts were subjected to oxidative stress associated with in vitro ischemic-reperfusion injury. The results indicated that Terminalia arjuna augments endogenous antioxidant compounds and prevents oxidative stress in the rat heart (Gauthaman et al 2001). Researchers evaluated the antioxidant and hypocholesterolemic effects of Terminalia arjuna tree bark and compared it with vitamin E in a randomized controlled trial. One hundred and five successive patients with coronary heart disease were divided into three groups of 35 patients each: group one receiving placebo capsules; group two vitamin E capsules 400 IU/day; and group three finely pulverized T. arjuna tree bark-powder, 500 mg daily. Lipids and lipid peroxide levels were determined at 30 days follow-up. No significant changes in total, HDL, LDL cholesterol and triglycerides levels were seen in groups one and two, but in group three there was a significant decrease in total cholesterol (12.7%) and LDL cholesterol (25.6%). Lipid peroxide levels decreased significantly in both groups two and three (Gupta et al 2001). The effect of orally administered Terminalia arjuna was investigated in experimental atherosclerosis in rabbits fed a cholesterol-rich diet. Atherosclerotic lesions of the aorta were examined histologically, and the herbal extract was found to have potent hypolipidemic properties, and partially inhibited atheroma formation (Shaila et al 1998). The effect of Terminalia arjuna on angina pectoris, congestive heart failure and left ventricular mass was studied in patients with myocardial infarction with angina and/or ischemic cardiomyopathy. The stem bark powder of T. arjuna was administered to 10 patients with postmyocardial infarction angina and in two patients with ischemic cardiomyopathy, 500 mg every eight hours, for a period of three months. These patients were also on conventional treatment comprising of nitrates, aspirin and/or calcium channel blockers, and were compared against twelve matching patients only receiving conventional treatment. The test group showed a significant improvement in left ventricular ejection fraction and a reduction in the left ventricular mass following therapy, compared to controls (Dwivedi and Jauhari 1997). Twelve patients with refractory chronic congestive heart failure, previous myocardial infarction and peripartum cardiomyopathy received Terminalia arjuna extract, 500 mg every eight hours, or a matching placebo, for 2 weeks each. Compared to placebo, Arjuna was associated with improvement in symptoms and signs of heart failure (Bharani et al 1995).
Antitumor: A bioassay-guided separation of gallic acid, ethyl gallate, and the flavone luteolin from the bark of Terminalia arjuna was examined for their inhibitory effects upon cancer cell growth, in vivo. The results supported the traditional use of T. arjuna in cancer treatment (Pettit et al 1996).
Toxicity: No data found.
Indications: Dysentery, cirrhosis, bronchitis, asthma, tuberculosis, hemorrhage, leucorrhea, menorrhagia, coronary heart disease, cardiovascular disease, diabetes, cancer, broken bones.
Contraindications: Pregnancy, constipation, dryness, Vatakopa.
Medicinal uses: Arjuna was introduced into the materia medica of Ayurveda as a treatment for heart disease by Vagbhata (c. 6-7th cent CE). This tropism to the heart however extends to the lungs as well, and to other vital organs such as the liver and intestines. Arjuna is used in both the treatment and prevention of cardiovascular disease, traditionally prepared as a milk decoction (kvatha), a process that renders the triterpenes more bioavailable (Tillotson 2001, 99). In the Ashtanga Hrdaya, Vagbhata mentions Arjuna in the treatment of wounds, hemorrhages and ulcers, applied topically as a powder (Srikanthamurthy 1994, 206). According to the Chakradatta, a churna of Arjuna consumed with ghee, milk or jaggery overcomes heart disease, chronic fever, and hemorrhaging, and promotes long life (Sharma 2002, 303). Similarly, the Chakradatta mentions a ghrita prepared with Arjuna, Bala, Nagabala (Sida spinosa) and Madhuka (Glycyrrhiza glabra) as an excellent treatment in heart disease, chest wounds, cough, pain and gout (Sharma 2002, 145). In the treatment of hemoptysis, Charaka recommends equal parts Arjuna with Raktachandana (Pterocarpus santalinus), along with sugar and rice water (Nakarni 1954, 1201). Sushruta mentions the usefulness of Arjuna as a vajikarana, combined with Chandana in spermatorrhea (Nakarni 1954, 1201). Soaked in the fresh juice of Vasaka, the Bhavaprakasha states that Arjuna is used in the treatment of consumption and hemoptysis (Srikanthamurthy 2000, 246). More recently, Arjuna has gained some notoriety as a major ingredient in the patented LIV-52 formula used in the treatment of liver disorders.
• Churna: 3-5 g b.i.d.-t.i.d. • Kvatha: 1:4, 30-90 mL b.i.d.-t.i.d. • Tincture: 1:3, 50% alcohol, 3-5 mL b.i.d.-t.i.d.